Threshold Pharmaceuticals, Inc.(THLD)- NASDAQ
Company Description
Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It develops its product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib bromide. It also seeks to optimize patient selectivity for its hypoxia-targeted... More
Sector: Healthcare
Industry: Biotechnology
Country: United States